Skip Navigation


The global source of news, directories, proprietary market research, and analysis for clinical trials professionals and patients

Home » Advanced Search

Search Results for pemetrexed

Perform Another (Advanced) Search

Related Words: pemetrexed

220 Results within Entire Site

Limit results to show:

1.  Study Posting (2917) Trial #158857, Non-Small Cell Lung Cancer, Beech Grove, IN
...II Trial of Docetaxel, Carboplatin and Bevacizumab as First-Line Treatment, Followed by Bevacizumab plus Pemetrexed versus Pemetrexed Alone as Second-Line Treatment of Stage IIIB or IV Non-Small Cell Lung Cancer ...
View Page

2. Clinical Trial Results by Drug Names
...Result Information Title of Study: A phase 1B study of erlotinib (Tarceva) in combination with pemetrexed (Alimta) in NSCLC. Fast Facts: Protocol number: BP18193 Sponsor: Hoffmann-La Roche Ltd Company division ...
...maximum tolerated dose (MTD) and safety profile of a combination of Tarceva (erlotinib) and Alimta (pemetrexed) in patients with non-small cell lung cancer (NSCLC). Study center(s) : 4 centers in ...
View Page

3.  Newly Approved Drug Therapies (849) Alimta (pemetrexed for injection), Eli Lilly,
...Newly Approved Drug Therapies (849) Alimta (pemetrexed for injection), Eli Lilly, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Alimta (pemetrexed for injection) Company: Eli Lilly Approval Status: Approved February 2004 Treatment Area: Mesothelioma General Information ...
View Page

4.  Study Posting (2246) Trial #155617, Lung Cancer, Duarte, CA
...Study Posting (2246) Trial #155617, Lung Cancer, Duarte, CA Trial Information Phase 3 Study of Pemetrexed, Cisplatin and Radiotherapy followed by Consolidation Pemetrexed v Etoposide, Cisplatin and Radiotherapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Patients with ...
View Page

5.  Study Posting (4519) Trial #157934, Non-Small Cell Lung Cancer, Izmir, Turkey
...Cancer, Izmir, Turkey Trial Information AVAPERL1 Study: A Study of Avastin (bevacizumab) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small ...
...Pharmaceutical Official Scientific Title: Open-label study of bevacizumab maintenance therapy (AVASTIN®) with or without pemetrexed after first-line chemotherapy with bevacizumab-cisplatin-pemetrexed in patients with advanced, metastatic or recurrent ...
View Page

6.  Study Posting (4519) Trial #157928, Non-Small Cell Lung Cancer, Antalya, Turkey
...Cancer, Antalya, Turkey Trial Information AVAPERL1 Study: A Study of Avastin (bevacizumab) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small ...
...Pharmaceutical Official Scientific Title: Open-label study of bevacizumab maintenance therapy (AVASTIN®) with or without pemetrexed after first-line chemotherapy with bevacizumab-cisplatin-pemetrexed in patients with advanced, metastatic or recurrent ...
View Page

7.  Study Posting (4519) Trial #158016, Non-Small Cell Lung Cancer, Ankara, Turkey
...Cancer, Ankara, Turkey Trial Information AVAPERL1 Study: A Study of Avastin (bevacizumab) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small ...
...Pharmaceutical Official Scientific Title: Open-label study of bevacizumab maintenance therapy (AVASTIN®) with or without pemetrexed after first-line chemotherapy with bevacizumab-cisplatin-pemetrexed in patients with advanced, metastatic or recurrent ...
View Page

8.  Study Posting (4519) Trial #158105, Non-Small Cell Lung Cancer, Zürich, Switzerland
...Cancer, Zürich, Switzerland Trial Information AVAPERL1 Study: A Study of Avastin (bevacizumab) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small ...
...Pharmaceutical Official Scientific Title: Open-label study of bevacizumab maintenance therapy (AVASTIN®) with or without pemetrexed after first-line chemotherapy with bevacizumab-cisplatin-pemetrexed in patients with advanced, metastatic or recurrent ...
View Page

9.  Study Posting (4519) Trial #158011, Non-Small Cell Lung Cancer, Uppsala, Sweden
...Cancer, Uppsala, Sweden Trial Information AVAPERL1 Study: A Study of Avastin (bevacizumab) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small ...
...Pharmaceutical Official Scientific Title: Open-label study of bevacizumab maintenance therapy (AVASTIN®) with or without pemetrexed after first-line chemotherapy with bevacizumab-cisplatin-pemetrexed in patients with advanced, metastatic or recurrent ...
View Page

10.  Study Posting (4519) Trial #158012, Non-Small Cell Lung Cancer, Lund, Sweden
...Cancer, Lund, Sweden Trial Information AVAPERL1 Study: A Study of Avastin (bevacizumab) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small ...
...Pharmaceutical Official Scientific Title: Open-label study of bevacizumab maintenance therapy (AVASTIN®) with or without pemetrexed after first-line chemotherapy with bevacizumab-cisplatin-pemetrexed in patients with advanced, metastatic or recurrent ...
View Page

11.  Study Posting (4519) Trial #157973, Non-Small Cell Lung Cancer, Linkoeping, Sweden
...Cancer, Linkoeping, Sweden Trial Information AVAPERL1 Study: A Study of Avastin (bevacizumab) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small ...
...Pharmaceutical Official Scientific Title: Open-label study of bevacizumab maintenance therapy (AVASTIN®) with or without pemetrexed after first-line chemotherapy with bevacizumab-cisplatin-pemetrexed in patients with advanced, metastatic or recurrent ...
View Page

12.  Study Posting (4519) Trial #158000, Non-Small Cell Lung Cancer, Palma de Mallorca, Spain
...de Mallorca, Spain Trial Information AVAPERL1 Study: A Study of Avastin (bevacizumab) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small ...
...Pharmaceutical Official Scientific Title: Open-label study of bevacizumab maintenance therapy (AVASTIN®) with or without pemetrexed after first-line chemotherapy with bevacizumab-cisplatin-pemetrexed in patients with advanced, metastatic or recurrent ...
View Page

13.  Study Posting (4519) Trial #157866, Non-Small Cell Lung Cancer, Madrid, Spain
...Cancer, Madrid, Spain Trial Information AVAPERL1 Study: A Study of Avastin (bevacizumab) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small ...
...Pharmaceutical Official Scientific Title: Open-label study of bevacizumab maintenance therapy (AVASTIN®) with or without pemetrexed after first-line chemotherapy with bevacizumab-cisplatin-pemetrexed in patients with advanced, metastatic or recurrent ...
View Page

14.  Study Posting (4519) Trial #157927, Non-Small Cell Lung Cancer, La Laguna, Spain
...La Laguna, Spain Trial Information AVAPERL1 Study: A Study of Avastin (bevacizumab) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small ...
...Pharmaceutical Official Scientific Title: Open-label study of bevacizumab maintenance therapy (AVASTIN®) with or without pemetrexed after first-line chemotherapy with bevacizumab-cisplatin-pemetrexed in patients with advanced, metastatic or recurrent ...
View Page

15.  Study Posting (4519) Trial #158132, Non-Small Cell Lung Cancer, St Petersburg, Russian Federation
...Petersburg, Russian Federation Trial Information AVAPERL1 Study: A Study of Avastin (bevacizumab) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small ...
...Pharmaceutical Official Scientific Title: Open-label study of bevacizumab maintenance therapy (AVASTIN®) with or without pemetrexed after first-line chemotherapy with bevacizumab-cisplatin-pemetrexed in patients with advanced, metastatic or recurrent ...
View Page

16.  Study Posting (4519) Trial #157903, Non-Small Cell Lung Cancer, Moscow, Russian Federation
...Moscow, Russian Federation Trial Information AVAPERL1 Study: A Study of Avastin (bevacizumab) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small ...
...Pharmaceutical Official Scientific Title: Open-label study of bevacizumab maintenance therapy (AVASTIN®) with or without pemetrexed after first-line chemotherapy with bevacizumab-cisplatin-pemetrexed in patients with advanced, metastatic or recurrent ...
View Page

17.  Study Posting (4519) Trial #158049, Non-Small Cell Lung Cancer, Krasnodar, Russian Federation
...Krasnodar, Russian Federation Trial Information AVAPERL1 Study: A Study of Avastin (bevacizumab) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small ...
...Pharmaceutical Official Scientific Title: Open-label study of bevacizumab maintenance therapy (AVASTIN®) with or without pemetrexed after first-line chemotherapy with bevacizumab-cisplatin-pemetrexed in patients with advanced, metastatic or recurrent ...
View Page

18.  Study Posting (4519) Trial #158046, Non-Small Cell Lung Cancer, Irkutsk, Russian Federation
...Irkutsk, Russian Federation Trial Information AVAPERL1 Study: A Study of Avastin (bevacizumab) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small ...
...Pharmaceutical Official Scientific Title: Open-label study of bevacizumab maintenance therapy (AVASTIN®) with or without pemetrexed after first-line chemotherapy with bevacizumab-cisplatin-pemetrexed in patients with advanced, metastatic or recurrent ...
View Page

19.  Study Posting (4519) Trial #158042, Non-Small Cell Lung Cancer, Balashikha, Russian Federation
...Balashikha, Russian Federation Trial Information AVAPERL1 Study: A Study of Avastin (bevacizumab) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small ...
...Pharmaceutical Official Scientific Title: Open-label study of bevacizumab maintenance therapy (AVASTIN®) with or without pemetrexed after first-line chemotherapy with bevacizumab-cisplatin-pemetrexed in patients with advanced, metastatic or recurrent ...
View Page

20.  Study Posting (4519) Trial #157971, Non-Small Cell Lung Cancer, Porto, Portugal
...Cancer, Porto, Portugal Trial Information AVAPERL1 Study: A Study of Avastin (bevacizumab) With or Without Pemetrexed as Maintenance Therapy After Avastin in First Line in Patients With Non-Squamous Non-Small ...
...Pharmaceutical Official Scientific Title: Open-label study of bevacizumab maintenance therapy (AVASTIN®) with or without pemetrexed after first-line chemotherapy with bevacizumab-cisplatin-pemetrexed in patients with advanced, metastatic or recurrent ...
View Page


Jobson Medical Information

Copyright © 2008 Jobson Medical Information LLC.


Designed by Piehead Productions LLC.